Samantha Rishbeth

Samantha Rishbeth is a seasoned pharmacovigilance professional currently serving as the Director of the QPPV Office at Sandoz. With previous roles including Associate Director of PV Agreements at GSK and Director of PV Alliance Management at Haleon, Samantha has developed extensive global safety knowledge across pharmaceuticals and consumer health. Known for strong project management and leadership skills, they excel in building stakeholder relationships and implementing risk-proportionate safety processes. Samantha holds a BSc (Hons) in Biology from the University of Southampton and is recognized as a credible expert in the field of pharmacovigilance.